Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Non-Scarring Alopecia in Black Women: Diagnosis, Impact, and Emerging Evidence
Description
The talk reviewed non-scarring alopecia in Black women, emphasizing that hair loss is deeply tied to culture, identity, beauty, and self-confidence, with major emotional, social, and financial burden. It highlighted that clinicians may underuse scalp biopsy, yet biopsy often changes the diagnosis and can build trust; frontal hairline disease in particular is frequently misclassified, and traction alopecia may be overcalled when other etiologies such as alopecia areata or fibrosing alopecias are present. For alopecia areata, the speaker noted classic features, common autoimmune and psychiatric comorbidities, and the ongoing uncertainty about whether it is truly more common in Black patients versus being confounded by hair color and other factors. She also pointed out that clinical trials for new AA treatments have included too few Black and Latino participants. In female pattern hair loss, data are limited, but Black women may show more vertex involvement. Telogen effluvium was discussed as presentation-dependent, especially in locs or braids, and hair pull testing should distinguish telogen bulbs from broken hairs. Medication-related shedding, including GLP-1 agonists, was reviewed, with many cases occurring in people who already had hair loss. Finally, chemotherapy-induced alopecia and cooling caps were discussed, with one study in Black women showing unexpectedly poor outcomes and increased distress, underscoring the need for better inclusive research and individualized care.
View moreConclusions
- Non-scarring alopecia in Black women has a major quality-of-life impact, with especially high mental, social, and activity burden and frequent dissatisfaction with current treatments.
- Scalp biopsy is underused but often changes the diagnosis in Black women with alopecia, suggesting that clinical overcalling of traction alopecia and multifactorial hair loss is common.
- Frontal hairline and vertex hair loss in Black women can be diagnostically misleading, so clinicians should have a low threshold to biopsy when the pattern is uncertain.
- Alopecia areata is a complex autoimmune disease with common associations to atopy, thyroid disease, psychiatric disease, and possibly other systemic comorbidities.
- The apparent link between alopecia areata and race is inconsistent across studies, and some evidence suggests hair color or other confounders may explain part of the association.
- Current alopecia areata trials and emerging treatments still lack adequate racial diversity, limiting how confidently results can be applied to Black patients.
- Female pattern hair loss in Black women may more often show vertex scalp involvement, indicating that its presentation may differ from that seen in other groups.
- Telogen effluvium in Black women can be missed or misread because protective styles such as locs or braids change how shedding appears.
- The hair pull test remains useful across hair textures, but clinicians must distinguish true telogen hairs from broken hairs to avoid misdiagnosis.
- Medication-related hair loss, including from GLP-1 agonists, is usually uncommon and often occurs on a background of pre-existing alopecia rather than as a wholly new problem.
- Acquired trichorrhexis nodosa and other breakage disorders improve most with moisturizing, reduced tension, and better hair-care practices rather than alopecia medications.
- Scalp cooling for chemotherapy-induced alopecia may be less effective or less tolerable in Black women with certain hair types and styling practices, so treatment strategies need better tailoring.
- Hair texture changes such as the downy hair sign can be an important clue to non-scarring alopecia from connective tissue disease, including acute lupus alopecia.
- Douglas et al. IJWD, 2025.
- Ho et al., JAAD, 2024.
- Chen et al., 2024.
- Feaster and Amy J. McMichael. Epidemiology of alopecia areata in Black patients: A retrospective chart review. JAAD, 2022.#10.1016/j.jaad.2022.01.033
- Gadre, 2024.
- Alhanshali et al., 2023.
- Burke et al., 2025, Journal of the American Academy of Dermatology.
- Araoye et al., 2020.
- “Hair pull test: A clinical update for patients with Asian- and Afro-textured hair.”#10.1016/j.jaad.2020.11.057
- “Downy hair sign,” Chen et al., 2024, JAAD.